Funder: AMGEN, S.A.
date_range Duration: from 04 December 2013 to 03 December 2014 (12 months) Finished
euro 36,300.00 EUR

Of National scope.

Medicamentos Biotecnológicos: de la Biología Molecular a las Terapias Humanas

Call: (AMGEN, S.A.)

Researchers